What is a Shareholder Protection Rights Agreement?

A Shareholder Protection Rights Agreement, often referred to as a "poison pill," is a defensive strategy adopted by a company's board of directors to prevent hostile takeovers. It typically grants existing shareholders the right to purchase additional shares of the company's stock at a discount if an unwanted entity acquires a certain percentage of the company's shares without the board's approval.

How does Parker-Hannifin's new Rights Agreement work?

For every share of Parker-Hannifin common stock owned, shareholders will receive one Right. If an individual or group acquires 15% or more of the company's outstanding common stock without board approval, the Rights will become exercisable. At that point, Rights holders (excluding the acquirer) can purchase additional shares of Parker-Hannifin at a price that is intended to be significantly below market value, thereby diluting the acquirer's ownership stake.

Can the Board of Directors remove these Rights?

Yes, the Board of Directors has the option to redeem all outstanding Rights for a nominal amount ($0.01 per Right) at any time before the "flip-in" event occurs (i.e., before an acquirer reaches the 15% ownership threshold). This provides flexibility to negotiate with potential acquirers or to approve transactions that are deemed to be in the best interest of shareholders.

Will this Rights Agreement prevent any acquisition of Parker-Hannifin?

The Rights Agreement is not designed to prevent all acquisitions. Instead, it aims to give the Board leverage to negotiate for a higher price and better terms for shareholders in the event of an unsolicited takeover attempt. It discourages hostile bids by making them more expensive and dilutive, encouraging potential acquirers to negotiate directly with the Board.

PH 8-K: Material Agreements & Shareholder Matters

Summary

Parker-Hannifin Corporation (PH) has filed an 8-K report on February 8, 2007, detailing the adoption of a new Shareholder Protection Rights Agreement, effective February 17, 2007. This agreement introduces a "poison pill" mechanism designed to deter hostile takeovers. Under this plan, existing shareholders will receive one "Right" for each share of common stock owned. These Rights will become exercisable if an individual or group acquires beneficial ownership of 15% or more of the company's outstanding common stock without the board's approval. The primary purpose of this Rights Agreement is to provide the Board of Directors with a tool to enhance shareholder value in the event of an unsolicited takeover attempt. While not designed to prevent all takeovers, it aims to discourage any individual or entity from gaining control without negotiating with the Board. The agreement allows the Board to redeem the Rights for $0.01 per Right under certain conditions, specifically before a hostile acquirer crosses the 15% ownership threshold.

Key Highlights

1Parker-Hannifin has adopted a new Shareholder Protection Rights Agreement, effective February 17, 2007.
2The agreement will issue one "Right" per outstanding share of common stock.
3These Rights are triggered if an entity acquires 15% or more of the company's common stock without board approval.
4Upon triggering, Rights holders will be entitled to purchase shares of common stock at a discounted price, potentially diluting an acquirer's stake.
5The Board retains the option to redeem all outstanding Rights for $0.01 per Right before a hostile acquisition threshold is met.
6The Rights Agreement is intended to protect shareholder value from coercive or unfair takeover tactics.
7This action replaces a previous Shareholder Protection Rights Agreement set to expire.

Parker-Hannifin Corp 8-K Report, Material Agreement (Feb 8, 2007)

Summary

Key Highlights

Frequently Asked Questions